Yaxian Wu

1.5k total citations
60 papers, 1.2k citations indexed

About

Yaxian Wu is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yaxian Wu has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Immunology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yaxian Wu's work include Immune Response and Inflammation (10 papers), NF-κB Signaling Pathways (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Yaxian Wu is often cited by papers focused on Immune Response and Inflammation (10 papers), NF-κB Signaling Pathways (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Yaxian Wu collaborates with scholars based in China, Macao and United States. Yaxian Wu's co-authors include Qingfeng Pang, Feng Qian, Lei Sun, Bin-bin Wan, Yunjuan Nie, Huiqiong He, Junliang Chen, Yunhe Ding, Dan Chen and Mudan Lu and has published in prestigious journals such as The Journal of Immunology, Journal of Applied Physics and Journal of Agricultural and Food Chemistry.

In The Last Decade

Yaxian Wu

59 papers receiving 1.1k citations

Peers

Yaxian Wu
An Chen China
Huan Zhou China
Fatma Saaoud United States
An Chen China
Yaxian Wu
Citations per year, relative to Yaxian Wu Yaxian Wu (= 1×) peers An Chen

Countries citing papers authored by Yaxian Wu

Since Specialization
Citations

This map shows the geographic impact of Yaxian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaxian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaxian Wu more than expected).

Fields of papers citing papers by Yaxian Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaxian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaxian Wu. The network helps show where Yaxian Wu may publish in the future.

Co-authorship network of co-authors of Yaxian Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaxian Wu. A scholar is included among the top collaborators of Yaxian Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaxian Wu. Yaxian Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Jun‐Lin, et al.. (2025). Naringenin inhibits ferroptosis to reduce radiation-induced lung injury: insights from network Pharmacology and molecular docking. Pharmaceutical Biology. 63(1). 1–10. 3 indexed citations
2.
Sun, Jiaojiao, et al.. (2025). Mitochondrial-related genome-wide Mendelian randomization identifies putatively causal genes in the pathogenesis of sepsis. Surgery. 181. 109150–109150. 3 indexed citations
3.
Wu, Yaxian, et al.. (2024). RTA408 alleviates lipopolysaccharide-induced acute lung injury via inhibiting Bach1-mediated ferroptosis. International Immunopharmacology. 142(Pt B). 113250–113250. 7 indexed citations
4.
Tong, Ying, et al.. (2024). MiR-196a-5p hinders vascular smooth muscle cell proliferation and vascular remodeling via repressing BACH1 expression. Scientific Reports. 14(1). 16904–16904. 2 indexed citations
5.
Wu, Yaxian, et al.. (2024). Sophoricoside ameliorates methicillin-resistant Staphylococcus aureus-induced acute lung injury by inhibiting Bach1/Akt pathway. Phytomedicine. 132. 155846–155846. 6 indexed citations
6.
Sun, Jiaojiao, Dapeng Liu, Shengpeng Li, et al.. (2024). Deletion of BTB and CNC Homology 1 Protects Against Staphylococcus aureus–Induced Acute Lung Injury. The Journal of Infectious Diseases. 231(3). 734–745. 1 indexed citations
7.
Wu, Yaxian, et al.. (2024). A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients. Cancer Immunology Immunotherapy. 73(1). 14–14. 3 indexed citations
8.
Wu, Yaxian, Shan Xing, Yu Wang, et al.. (2023). Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer. 11(8). e006552–e006552. 1 indexed citations
9.
Jin, Ming, Xiaowen Liu, Yaxian Wu, et al.. (2023). Association of pre-/early pregnancy high blood pressure and pregnancy outcomes: a systemic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 37(1). 2296366–2296366. 7 indexed citations
10.
Tong, Ying, Huimin Zhao, Yaru Zhang, et al.. (2023). MiR-155-5p Attenuates Vascular Smooth Muscle Cell Oxidative Stress and Migration via Inhibiting BACH1 Expression. Biomedicines. 11(6). 1679–1679. 10 indexed citations
11.
Wu, Yaxian, et al.. (2023). A Hospital-Based Study on Congenital Heart Defects — Haidian District, Beijing Municipality, China, 2013–2022. China CDC Weekly. 5(36). 808–813. 2 indexed citations
12.
Sun, Lei, Haibo Zhang, Zhiming Wang, et al.. (2023). Staphylococcal virulence factor HlgB targets the endoplasmic-reticulum-resident E3 ubiquitin ligase AMFR to promote pneumonia. Nature Microbiology. 8(1). 107–120. 20 indexed citations
13.
Lai, Yanzhen, Yu Wang, Yaxian Wu, et al.. (2022). Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules. Cancer Control. 29. 2905522709–2905522709. 9 indexed citations
14.
Wu, Yaxian, Yingying Wang, Zhiqi Gao, et al.. (2021). Ethyl ferulate protects against lipopolysaccharide-induced acute lung injury by activating AMPK/Nrf2 signaling pathway. Acta Pharmacologica Sinica. 42(12). 2069–2081. 44 indexed citations
15.
Nie, Yunjuan, Dan Zhang, Feng Qian, & Yaxian Wu. (2019). Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation. International Immunopharmacology. 74. 105696–105696. 17 indexed citations
16.
Huang, Jianfeng, Wenjun Jiang, Ping Wu, et al.. (2019). <p>Systematic nutrition management for locally advanced nasopharyngeal carcinoma patients undergoing radiotherapy</p>. OncoTargets and Therapy. Volume 12. 8379–8386. 18 indexed citations
17.
Wu, Yaxian, Huiqiong He, Yunjuan Nie, et al.. (2017). Protostemonine effectively attenuates lipopolysaccharide-induced acute lung injury in mice. Acta Pharmacologica Sinica. 39(1). 85–96. 43 indexed citations
18.
He, Huiqiong, Yaxian Wu, Yunjuan Nie, et al.. (2017). LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway. Acta Pharmacologica Sinica. 38(3). 342–350. 21 indexed citations
19.
Wu, Yaxian, et al.. (2010). Conductance of Graphene Nanoribbon Junctions and the Tight Binding Model. Nanoscale Research Letters. 6(1). 62–62. 41 indexed citations
20.
Wang, Hong, Zhiyuan Tang, Lei Sun, et al.. (2009). Capacitance performance enhancement of TiO 2 doped with Ni and graphite. Rare Metals. 28(3). 231–236. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026